James P Snyder

This inventor holds 29 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Emory University, Cancer Research Technology Limited, Children's Healthcare of Atlanta, Inc.. Active years: 2000-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James P Snyder. Retrieved from https://idiyas.com/inventor/james-p-snyder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 3)

% Patents Active = 75.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 133(Granted Patents)

Company Filing History:

Cancer Research Technology Limited

patents

3 out of 87

Children's Healthcare of Atlanta, Inc.

patents

4. 3 out of 167

Imperial Innovations Limited

patents

5. 2 out of 112

Imperial College of Science, Technology and Medicine

patents

6. 2 out of 52

Ip2ipo Innovations Limited

where one patent can have more than one assignee

Years Active: 2000-2023

Loading Chart...

Areas of Expertise:

CDK Inhibitors

CXCR4 Antagonists

NMDA Receptor Antagonists

Pyrazolo Compounds

Quinazoline Compounds

Myxovirus Therapeutics

Triptolide Analogs

Curcumin Analogs

Phosphotidylinositol Inhibitors

Imidazolyl Amide Compounds

Anticancer Agents

Esterification Methods

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11566029 - Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use (2023-01-31),

2. 10947225 - Phosphotidylinositol 3-kinase inhibitors (2021-03-16),

3. 10927119 - Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use (2021-02-23),

4. 10450293 - Chemokine CXCR4 and CCR5 receptor modulators and uses related thereto (2019-10-22),

5. 10414772 - Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use (2019-09-17),

6. 9932344 - Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use (2018-04-03),

7. 9932317 - Quinazoline compounds and their use in therapy (2018-04-03),

8. 9676727 - Myxovirus therapeutics, compounds, and uses related thereto (2017-06-13),

9. 9499489 - Myxovirus therapeutics, compounds, and uses related thereto (2016-11-22),

10. 9365523 - Imidazolyl amide compounds and uses related thereto (2016-06-14),

11. 9079852 - NMDA receptor antagonists for neuroprotection (2015-07-14),

12. 8729059 - Paramyxovirus family inhibitors and methods of use thereof (2014-05-20),

13. 8507673 - Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compounds (2013-08-13),

14. D685387 - Graphical user interface for a display screen or a portion thereof (2013-07-02),

15. 8420680 - NMDA receptor antagonists for neuroprotection (2013-04-16),

Title: The Innovative Journey of James P Snyder

Introduction: James P Snyder, a talented inventor based in Atlanta, Georgia, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: James P Snyder's latest patents include a cutting-edge software application for optimizing energy consumption in commercial buildings and a revolutionary medical device for monitoring vital signs remotely.

Career Highlights: With over two decades of experience in the tech industry, James P Snyder has a proven track record of developing innovative solutions. He has worked for leading tech companies, where he spearheaded research and development projects that have resulted in multiple successful patent applications.

Collaborations: Throughout his career, James P Snyder has collaborated with top engineers, scientists, and designers to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: James P Snyder's passion for innovation and his dedication to pushing the boundaries of technology have established him as a respected figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.